Michael D. Barron
Michael D. Barron is a senior business development scientist at Cardinal Health Pharmaceutical Development
Articles
Implementing Successful Stability Testing Operations
February 1st 2003Stability studies are essential to every phase of a drug's life cycle. They not only document that a product will maintain its potency during its stated shelf life, but that it will do so under a variety of storage conditions as well.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: December 20th 2024 | Updated: December 23rd 2024
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Published: November 25th 2024 | Updated: December 23rd 2024
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Published: February 23rd 2024 | Updated: December 23rd 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 23rd 2024
FDA Creates CDER Center for Real-World Evidence Innovation
